Mutlu, H. 2016. Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2 , 316-318.

Mutlu, H., (2016). Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 316-318.

Mutlu, HASAN. "Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 316-318, 2016

Mutlu, HASAN. "Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.316-318, 2016

Mutlu, H. (2016) . "Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.316-318.

@article{article, author={HASAN MUTLU}, title={Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2016, pages={316-318} }